tion conditions/amounts are given in parentheses. Under these
conditions the following analytical data were obtained (Fig. 1).
δ (250 MHz; 0.1 M NaOD in D O; HDO) 1.24 (3 H, dd, J 13.2
and MeOH. The product was cleaved from the resin by treat-
ment with NaOH (400 µl; 0.1 M), and the resin was washed
successively with water and MeOH. Aq. HCl (400 µl, 0.1 M)
was added to the combined filtrate and the solvents were
removed in vacuo. The solid residue (10 mg) was re-dissolved in
50% aq. MeCN (2 ml) and purified by preparative RP-HPLC.
Fractions containing the product were collected, and concen-
trated to dryness in vacuo to obtain phosphinic undecapeptide
LMF-AlaΨ{PO H-CH }Gly-FAPFFG 12 as a solid mixture of
H
2
and 7.2, CH ), 1.76 (2 H, dd, J 12.2 and 6.0, PCH ), 2.31 (2 H,
3
2
dd, J 11.9 and 6.9, CH CO), 3.70 (2 H, m, CHMeP), 4.56 (2 H,
2
d, J 4.7, CH ᎐CHCH O), 5.24 (1 H, d, J 11.0, cis CH ᎐CH-
2
2
2
CH O), 5.30 (1 H, d, J 18.0, trans CH ᎐CHCH O), 5.97 (1 H,
2
2
2
m, CH ᎐CHCH O); δ (250 MHz; 0.1 M NaOD in D O; H PO )
2
2
P
2
3
4
ϩ
4
2
1.6; m/z (ES-MS) 265.9 ([M ϩ H] . C H NO P requires m/z
9 17 6
ϩ
66.1), 287.9 ([M ϩ Na] . C H NNaO P requires m/z 288.1).
2
2
two diastereomers (5 mg, 45% based on the initial resin load-
ing or 90% based on loading of Fmoc-FAPFFG-O-POEPS-3);
9
16
6
13
Phosphinic undecapeptide 12. POEPS-3 resin (1.5 g, 0.3
RP-HPLC (2 peaks, 36.7 and 37.0 min). δ (250 MHz; 0.1 M
P
mmol) was swelled in anhydrous DCM (50 ml) and drained
after a period of 10 min. A solution of Fmoc-Gly-OH (267 mg,
NaOD in D O; H PO ) 39.2 and 39.7; m/z (MALDI-TOF)
2
3
4
ϩ
1240.0 ([M ϩ H] . C H N O PS requires m/z, 1239.6),
62
84 10 13
ϩ
0
.9 mmol) and N-methylimidazole (54 µl, 0.675 mmol)
in anhydrous DCM (30 ml) was mixed with MSNT (267 mg,
.9 mmol) and added to the resin. After 60 min the resin
1262.0 ([M ϩ Na] . C H N NaO PS requires m/z, 1261.6),
62 83 10 13
ϩ
1278.0 ([M ϩ K] . C H KN O PS requires m/z, 1277.6).
62
83
10 13
0
Amino acid analysis: Gly 1.04, Ala 1.02, Met 0.93, Leu 0.95,
was drained, washed with anhydrous DCM × 3, and another
coupling of Fmoc-Gly-OH/MSNT/N-methylimidazole was
performed for 60 min. The resin was drained and washed suc-
cessively with DCM, DMF × 3, (5% diisopropylethylamine in
Phe 4.10, Pro 0.95 (LMF-AlaΨ{PO H-CH }Gly-FAPFFG
requires Gly 1, Ala 1, Met 1, Leu 1, Phe 4, Pro 1).
2
2
Acknowledgements
DMF) × 2, DMF × 3, and DCM, and lyophilised. Loading:
Ϫ1
0
.20 mmol g . A fraction of the resin (840 mg, 0.167 mmol)
This work has been supported by VækstFonden through
Osteopro A/S (Denmark, www.osteopro.dk) and by the
SPOCC program under the Danish National Research
Foundation. Dr Charlotte Gotfredsen is kindly thanked for
was treated with piperidine to remove Fmoc, washed with
DMF, and treated with a solution of Fmoc-Phe-OPfp (278 mg,
0
1
.501 mmol) and Dhbt-OH (27 mg, 0.167 mmol) in DMF for
h. Similarly, Fmoc-protected amino acid Pfp esters of Phe,
1
acquiring MAS H NMR spectra.
Pro, Ala, and Phe were coupled using Dhbt-OH until a negative
Kaiser ninhydrin test was observed (amounts Fmoc-Pro-OPfp:
Ϫ1
2
53 mg, Fmoc-Ala-OPfp: 240 mg). Loading: 0.10 mmol g . A
References
small aliquot of the resin was treated with piperidine, washed
with DMF × 3 and with MeOH × 3 and treated with NaOH
0.1 M) to give hexapeptide FAPFFG. RP-HPLC (1 peak,
9.3 min); m/z (MALDI-TOF) 685.7 ([M ϩ H] . C H N O
37 45 6 7
ϩ
requires m/z, 685.3), 707.8 ([M ϩ Na] . C H N NaO requires
1
M. C. Allen, W. Fuhrer, B. Tuck, R. Wade and J. M. Wood, J. Med.
Chem., 1989, 32, 1652.
P. A. Bartlett, J. E. Hanson and P. P. Giannousis, J. Org. Chem.,
1990, 55, 6268.
(
2
2
ϩ
3 C. Verbruggen, S. De Craecker, P. Rajan, X.-Y. Jiao, M. Borloo,
K. Smith, A. H. Fairlamb and A. Haemers, Bioorg. Med. Chem.
Lett., 1996, 6, 253.
37
44
6
7
m/z, 708.3).
A fraction of the resin (200 mg, 40 µmol) was treated with
piperidine and washed successively with DMF and DCM. Neat
Et N (111 µl, 800 µmol) was added to the resin followed by a
solution of acryloyl chloride (33 µl, 400 µmol) in DCM. The
reaction was complete within 5 min according to Kaiser
ninhydrin test. The resin was drained, washed successively with
DCM and MeOH × 3, and lyophilised. A small aliquot of the
resin was treated with NaOH (0.1 M) to give acryloylated
hexapeptide Acr-FAPFFG 9 RP-HPLC (1 peak, 39.0 min);
4
I. Yiallouros, S. Vassiliou, A. Yiotakis, R. Zwilling, W. Stöcker and
V. Dive, Biochem. J., 1998, 331, 375.
3
5 M. Whittaker, C. D. Floyd, P. Brown and A. J. H. Gearing, Chem.
Rev., 1999, 99 , 2735.
6 J. Buchardt, M. Ferreras, C. Krog-Jensen, J.-M. Delaissé, N. T.
Foged and M. Meldal, Chem. Eur. J., 1999, 5, 2877.
7
S. Vassiliou, A. Mucha, P. Cuniasse, D. Georgiadis, K. Lucet-
Levannier, F. Beau, R. Kannan, G. Murphy, V. Knäuper, M.-C.
Rio, P. Basset, A. Yiotakis and V. Dive, J. Med. Chem., 1999, 42,
2
610.
ϩ
m/z (MALDI-TOF) 761.8 ([M ϩ Na] . C H N NaO requires
8 A. Yiotakis, S. Vassiliou, J. Jirácek and V. Dive, J. Org. Chem., 1996,
61 , 6601.
40
46
6
8
m/z, 761.3).
9
G. Fields, Z. Tian and G. Barany, in Synthetic Peptides: A Users
Guide, ed. G. A. Grant, W. H. Freeman and Company, New York,
A fraction of the resin (50 mg, 10 µmol) was placed in a 5 ml
reaction vial and a solution of 3 (23.2 mg, 120 µmol) and BSA
90 µl, 360 µmol) in degassed DCE (1 ml) was added to the
1
992, p. 77.
(
1
0 J. K. Thottathil, D. E. Ryono, C. A. Przybyla, J. L. Moniot and
resin. The resin slurry was purged with Ar for 1 min, and the
vial was closed and heated to 100 ЊC for 4 h, after which it was
cooled to rt and washed with DCM and lyophilised. A small
aliquot of the resin was washed with MeOH and treated with
NaOH (0.1 M) to give phosphinic octapeptide Alloc-AlaΨ-
R. Neubeck, Tetrahedron Lett., 1984, 25, 4741.
11 E. A. Boyd, M. Corless, K. James and A. C. Regan, Tetrahedron
Lett., 1990, 31, 2933.
2 P. H. Dorff, G. Chiu, S. W. Goldstein and B. P. Morgan, Tetrahedron
Lett., 1998, 39, 3375.
3 J. Buchardt and M. Meldal, Tetrahedron Lett., 1998, 39, 8695.
4 M. Grötli, C. H. Gotfredsen, J. Rademann, J. Buchardt, A. J. Clark,
J. Duus and M. Meldal, J. Comb. Chem., 2000, 2, 108.
15 B. Blankemeyer-Menge, M. Nimtz and R. Frank, Tetrahedron Lett.,
1990, 31, 1701.
6 E. K. Baylis, C. D. Campbell and J. G. Dingwall, J. Chem. Soc.,
Perkin Trans. 1, 1984, 2845.
1
1
1
{
PO H-CH }Gly-FAPFFG 11. RP-HPLC (1 peak, 35.6 min);
2 2
ϩ
m/z (MALDI-TOF) 932.7 ([M ϩ H] . C H N O P requires
m/z, 932.4), 954.8 ([M ϩ Na] . C H N NaO P requires m/z,
9
46
59
7
12
ϩ
4
6
58
7
12
ϩ
54.4), 970.7 ([M ϩ K] . C H KN O P requires m/z, 970.4).
46 58 7 12
1
A solution of Pd(PPh ) (32 mg, 30 µmol) in CHCl –AcOH–
3
4
3
N-ethylmorpholine 92.5:5:2.5 (800 µl) was added to the resin
and left for 15 min. The resin was washed successively with
1
7 S. A. Kates, S. B. Daniels and F. Albericio, Anal. Biochem., 1993,
2
12, 303.
CHCl , DMF × 3, (0.5% Et NCS Na in DMF) × 3 and DMF.
3
2
2
18 M. Meldal, in Solid Phase Peptide Synthesis (Methods in
Enzymology Vol 289), ed. G. Fields, Academic Press, New York,
1997, p. 83.
A solution of Fmoc-Phe-OPfp (33 mg, 60 mmol) and Dhbt-OH
0.6 mg, 10 µmol) in DMF was added to the resin and allowed
(
1
2
9 W. Li and B. Yan, J. Org. Chem., 1998, 63, 4092.
0 E. Atherton and R. C. Sheppard, J. Chem. Soc., Chem. Commun.,
to react for a period of 16 h. Similarly, Fmoc-protected amino
acid Pfp esters of Met and Leu were coupled using Dhbt-OH
1
985, 165.
(
amounts Met: 16 mg, 30 µmol and Leu: 16 mg, 30 µmol). After
2
2
1 M. Bodansky and M. A. Bednarek, J. Protein Chem., 1989, 8, 461.
2 R. Knorr, A. Trzeciak, W. Bannwarth and D. Gillesen, Tetrahedron
Lett., 1989, 30, 1927.
the final coupling the resin was washed with DMF, treated with
piperidine to remove Fmoc, and washed successively with DMF
3
310
J. Chem. Soc., Perkin Trans. 1, 2000, 3306–3310